Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915..
Clinical, Immunologic, and Molecular Spectrum of Patients with Immunodeficiency, Centromeric instability, and Facial anomalies (ICF) syndrome: a Systematic Review. Endocr Metab Immune Disord Drug Targets. 2020.
Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression. Int J Pharm. 2020:119236.
Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome. Cytokine. 2020;128:155002.
Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol. 2020:173235.
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
Silencing of p68 and STAT3 synergistically diminishes cancer progression. Life Sci. 2020:117499.
Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine. Immunology. 2019.
Conjugated CAR T cell one step beyond conventional CAR T cell for a promising cancer immunotherapy. Cell Immunol. 2019:103963..
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019:116952..
Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. Int Immunopharmacol. 2019;78:106087..
The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.
Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function. J Cell Biochem. 2018.
T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. J Reprod Immunol. 2018;131:21-29.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis. Cell Immunol. 2015;293(2):113-121..